• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分泌性癌:加拿大东部的经验和文献回顾。

Secretory carcinoma: the eastern Canadian experience and literature review.

机构信息

Division of Otolaryngology - Head & Neck Surgery, Department of Surgery, Dalhousie University, 5820 University Ave. 3rd Floor Dickson Bldg, Halifax, NS, B3H 2Y9, Canada.

Department of Pathology, Dalhousie University, Halifax, NS, Canada.

出版信息

J Otolaryngol Head Neck Surg. 2018 Nov 16;47(1):69. doi: 10.1186/s40463-018-0315-6.

DOI:10.1186/s40463-018-0315-6
PMID:30446016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6240209/
Abstract

BACKGROUND

Secretory Carcinoma (SC) is a recently described malignancy affecting salivary glands of the head and neck, with a paucity of evidence regarding the natural history, morbidity, and mortality. This study aimed to investigate the current treatment options utilized for SC, as well as its presentation and outcomes.

METHODS

This study is a retrospective case series and includes patients diagnosed with SC at four Maritime Canadian institutions. Literature review of patient outcomes following treatment of SC is also included.

RESULTS

Thirteen patients were identified. Parotid was the most common subsite (69%), followed by minor salivary gland (23%) and submandibular gland (8%). All patients were S100 positive and had at least one additional positive confirmatory stain, including mammaglobin, CK7, or vimentin. Two patients had N2b disease. All patients were treated with primary surgery, and four were offered adjuvant radiotherapy. There was one instance of locoregional recurrence, and one of metastasis. Three patients displayed perineural invasion on pathology, and one patient displayed lymphovascular invasion.

CONCLUSION

Secretory Carcinoma remains understudied regarding its natural history, presentation, and treatment options. This study is the largest single case series in Canada, and highlights the young age and possible aggressiveness of SC. As well, we provide the most comprehensive literature review to date, with a focus on treatment and outcomes for this disease entity.

摘要

背景

分泌性癌(SC)是一种新近描述的头颈部唾液腺恶性肿瘤,关于其自然史、发病率和死亡率的证据很少。本研究旨在探讨目前用于 SC 的治疗选择,以及其表现和结果。

方法

本研究是一项回顾性病例系列研究,包括在四个加拿大海洋机构诊断为 SC 的患者。还包括对 SC 治疗后患者结局的文献复习。

结果

共确定了 13 名患者。腮腺是最常见的部位(69%),其次是小唾液腺(23%)和下颌下腺(8%)。所有患者 S100 阳性,并且至少有一项额外的阳性确认染色,包括乳球蛋白、CK7 或波形蛋白。2 名患者有 N2b 疾病。所有患者均接受了原发性手术治疗,4 名患者接受了辅助放疗。有 1 例局部区域复发,1 例转移。3 名患者的病理显示有神经周围侵犯,1 名患者显示有血管侵犯。

结论

关于 SC 的自然史、表现和治疗选择,仍需要进一步研究。本研究是加拿大最大的单一病例系列研究,强调了 SC 的年轻年龄和可能的侵袭性。此外,我们提供了迄今为止最全面的文献综述,重点关注该疾病实体的治疗和结局。

相似文献

1
Secretory carcinoma: the eastern Canadian experience and literature review.分泌性癌:加拿大东部的经验和文献回顾。
J Otolaryngol Head Neck Surg. 2018 Nov 16;47(1):69. doi: 10.1186/s40463-018-0315-6.
2
Incidence of adenoid cystic carcinoma in nova scotia: 30-year population-based epidemiologic study.新斯科舍省腺样囊性癌的发病率:一项基于30年人群的流行病学研究。
J Otolaryngol Head Neck Surg. 2008 Oct;37(5):642-8.
3
Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature.硬腭发生的具有高级别组织学特征的涎腺乳腺样分泌癌:1例报告并文献复习
Int J Clin Exp Pathol. 2014 Dec 1;7(12):9008-22. eCollection 2014.
4
Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands.31 例 ETV6-NTRK3 融合基因阳性(乳腺型)涎腺分泌型癌患者的临床病理特征和预后分析。
Oral Oncol. 2018 Jul;82:29-33. doi: 10.1016/j.oraloncology.2018.04.022. Epub 2018 May 11.
5
Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.乳腺型分泌性涎腺癌,含有 ETV6-NTRK3 融合基因:一种迄今尚未描述的涎腺肿瘤实体。
Am J Surg Pathol. 2010 May;34(5):599-608. doi: 10.1097/PAS.0b013e3181d9efcc.
6
[Adenoid cystic carcinoma of the head and neck--a 10 years experience].[头颈部腺样囊性癌——十年经验]
Otolaryngol Pol. 2011 Sep;65(5 Suppl):6-11. doi: 10.1016/S0030-6657(11)70702-8.
7
Cytopathological features of secretory carcinoma of salivary glands and ancillary techniques in its diagnostics: impact of new Milan system for reporting salivary gland cytopathology.涎腺分泌性癌的细胞病理学特征及其诊断中的辅助技术:新的米兰涎腺细胞病理学报告系统的影响
APMIS. 2019 Jul;127(7):491-502. doi: 10.1111/apm.12950. Epub 2019 May 24.
8
Secretory Carcinoma of the Skin Harboring ETV6 Gene Fusions: A Cutaneous Analogue to Secretory Carcinomas of the Breast and Salivary Glands.携带ETV6基因融合的皮肤分泌性癌:一种与乳腺和唾液腺分泌性癌类似的皮肤肿瘤
Am J Surg Pathol. 2017 Jan;41(1):62-66. doi: 10.1097/PAS.0000000000000734.
9
Oncocytic carcinoma of the salivary glands: A Danish national study.涎腺嗜酸性细胞癌:一项丹麦全国性研究。
Auris Nasus Larynx. 2018 Aug;45(4):825-830. doi: 10.1016/j.anl.2017.10.001.
10
Secretory carcinoma of salivary gland origin: A recently established masquerader.涎腺来源的分泌性癌:一种新近确立的伪装者。
Indian J Cancer. 2021 Apr-Jun;58(2):278-284. doi: 10.4103/ijc.IJC_274_20.

引用本文的文献

1
Practical pathological methods for reliable diagnosis of secretory carcinomas of the salivary gland.用于可靠诊断唾液腺分泌性癌的实用病理方法。
Discov Oncol. 2025 Jul 3;16(1):1254. doi: 10.1007/s12672-025-03072-3.
2
Salivary gland secretory carcinoma presenting as a cervical soft tissue mass: a case report.表现为颈部软组织肿块的涎腺分泌癌:一例报告
J Med Case Rep. 2024 Feb 5;18(1):78. doi: 10.1186/s13256-024-04364-y.
3
MASC Gets UNMASKED: Visiting a Rare Tumor with Emphasis on Cytomorphological Features.MASC 被揭开面纱:探访一种罕见肿瘤,重点关注细胞形态学特征。

本文引用的文献

1
Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands.31 例 ETV6-NTRK3 融合基因阳性(乳腺型)涎腺分泌型癌患者的临床病理特征和预后分析。
Oral Oncol. 2018 Jul;82:29-33. doi: 10.1016/j.oraloncology.2018.04.022. Epub 2018 May 11.
2
Synchronous Parotid (Mammary Analog) Secretory Carcinoma and Acinic Cell Carcinoma: Report of a Case.同步性腮腺(乳腺样)分泌性癌与腺泡细胞癌:1例报告
Head Neck Pathol. 2019 Dec;13(4):686-691. doi: 10.1007/s12105-018-0935-1. Epub 2018 Jun 6.
3
The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
J Cytol. 2023 Oct-Dec;40(4):192-199. doi: 10.4103/joc.joc_155_22. Epub 2023 Oct 16.
4
Mammary Analogue Secretory Carcinoma of Submandibular Gland: A Case Report with Review of the Literature.下颌下腺乳腺样分泌癌:一例报告并文献复习
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):6059-6064. doi: 10.1007/s12070-021-02714-6. Epub 2021 Jul 2.
5
Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features.一组分泌性乳腺癌的临床病理特征和基因组特征,其中进展病例具有更复杂的基因组特征。
Diagn Pathol. 2022 Dec 31;17(1):101. doi: 10.1186/s13000-022-01284-7.
6
Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review.评估复发性涎腺癌挽救性手术后的生存情况:系统评价。
Head Neck. 2022 Aug;44(8):1961-1975. doi: 10.1002/hed.27062. Epub 2022 Apr 20.
7
Secretory carcinoma of the salivary gland, a rare entity: An international multi-institutional study.唾液腺癌,一种罕见的实体瘤:一项国际多机构研究。
Cancer Cytopathol. 2022 Sep;130(9):684-694. doi: 10.1002/cncy.22574. Epub 2022 Apr 6.
8
Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single-cell transcriptome analysis.通过单细胞转录组分析对脑脊液中肺癌脑转移的循环肿瘤细胞进行表征。
Clin Transl Med. 2020 Dec;10(8):e246. doi: 10.1002/ctm2.246.
分子检测在唾液腺癌鉴别诊断中的作用。
Am J Surg Pathol. 2018 Feb;42(2):e11-e27. doi: 10.1097/PAS.0000000000000980.
4
Molecular Profiling of Mammary Analog Secretory Carcinoma Revealed a Subset of Tumors Harboring a Novel ETV6-RET Translocation: Report of 10 Cases.乳腺类似分泌型癌的分子特征分析揭示了一类具有新型 ETV6-RET 易位的肿瘤:10 例报告。
Am J Surg Pathol. 2018 Feb;42(2):234-246. doi: 10.1097/PAS.0000000000000972.
5
A systematic review including an additional pediatric case report: Pediatric cases of mammary analogue secretory carcinoma.一项系统评价,包括一篇新增的儿科病例报告:乳腺样分泌癌的儿科病例
Int J Pediatr Otorhinolaryngol. 2017 Sep;100:187-193. doi: 10.1016/j.ijporl.2017.07.004. Epub 2017 Jul 6.
6
Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.涎腺来源乳腺样分泌癌的临床病理及分子特征
Pathol Res Pract. 2017 Sep;213(9):1112-1118. doi: 10.1016/j.prp.2017.07.017. Epub 2017 Jul 23.
7
Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib.伴有高级别转化、CDKN2A/B缺失、远处转移且对克唑替尼缺乏持续反应的涎腺分泌性癌
Int J Surg Pathol. 2017 Oct;25(7):613-618. doi: 10.1177/1066896917709350. Epub 2017 May 12.
8
Mammary analogue secretory carcinoma: A rare salivary gland tumour.乳腺样分泌癌:一种罕见的涎腺肿瘤。
S Afr Med J. 2017 Mar 29;107(4):304-306. doi: 10.7196/SAMJ.2017.v107i4.12228.
9
Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland.世界卫生组织头颈部肿瘤分类第4版更新:涎腺肿瘤
Head Neck Pathol. 2017 Mar;11(1):55-67. doi: 10.1007/s12105-017-0795-0. Epub 2017 Feb 28.
10
Mammary Analogue Secretory Carcinoma.乳腺样分泌性癌
Arch Pathol Lab Med. 2016 Sep;140(9):997-1001. doi: 10.5858/arpa.2015-0075-RS.